ClinicalTrials.Veeva

Menu

COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients

A

Alhasan Mujtaba Al-Mudhaffer

Status

Completed

Conditions

Covid19
Depression
Anxiety

Study type

Observational

Funder types

Other
NETWORK

Identifiers

Details and patient eligibility

About

The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety.

To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.

Enrollment

450 patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with COVID19 willing to participate in the study

Exclusion criteria

  • unwilling unable to read or interact with standardized questionnaire unconscious

Trial design

450 participants in 3 patient groups

mild covid
moderate covid
severe covid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems